 |
Legislation
Provisional
Remedy
Provisional
Remedy nº 2.039-20, of August 25, 2000
Published
in the Official Journal of the Union on 25.8.2000
Alters
provisions of Law No. 9.782, of January 26, 1999, which Defines
the National Sanitary Surveillance System, establishes the National
Sanitary Surveillance Agency and sets out other provisions.
THE
PRESIDENT OF THE REPUBLIC, in the use of the attributions vested
in him under Article 62 of the Constitution, adopts the following
Provisional Remedy:
Article
1 - The provisions of Law No. 9.782, of January 26, 1999, indicated
below, shall henceforth be in force with the following changes:
"Article
7 - .............................................................................
...............................................................................................
VII.
to authorize the operation of companies that manufacture, distribute
and import the products mentioned in Article 8 of this Law,
and that market medicines;
..............................................................................................
XXV.
to monitor the evolution of prices of medicines, health equipment,
components, inputs and services, with power to:
-
request,
at its discretion, information about production, inputs, raw
materials, sales and any other information held by private or
public corporations which perform activities of production,
distribution and marketing of goods and services provided for
in this item, keeping legal secrecy whenever the case;
-
carry
out examination of stock, papers and documents of any companies
or private or public corporations which perform activities of
production, distribution and marketing of goods and services
provided for in this item, keeping legal secrecy whenever the
case;
-
when
evidence of the existence of infractions provided for in items
III or IV of Article 20 of Law No. 8.884, of June 11, 1994,
is verified, by means of unjustified rise of prices or imposition
of excessive prices of goods and services referred to in these
items, summon those responsible in order for them to justify
their respective conduct within ten working days;
-
apply
the penalties provided for in Article 26 of Law No. 8.884, 1994;
XXVI
- to control, inspect and supervise, in the light of sanitary legislation,
the advertising and publicity of products subject to the sanitary
surveillance regimen.
.............................................................................................
Paragraph
4 - The Agency may devolve to an organization within the Ministry
of Health the discharge of functions listed in this article and
pertaining to medical, out-patient and hospital services, provided
for in Paragraphs 2 and 3 of Article 8 of Law No. 9.782, of 1999,
provided that interdictions defined in Paragraph 1 of this Article
are obeyed.
Paragraph
5 - The Agency shall always act in compliance with guidelines set
out by Law No. 8.080, of September 19, 1990, in order to continue
the development of the process of decentralization of activities
towards the States, the Federal District and the Municipalities,
provided that interdictions defined in Paragraph 1 of this Article
are obeyed.
Paragraph
6 - Decentralization referred to in the previous Paragraph shall
be carried out only after favorable opinions by the respective State,
District and Municipality Health Councils. (Re-edition)."
"Article
8 - .............................................................................
...............................................................................................
Paragraph
5 - The Agency may waive the registration of immune-biological products,
insect killers, medicines and other strategic inputs whenever they
are acquired through international multilateral organizations to
be used in public health programs by the Ministry of Health and
its related bodies.
Paragraph
6 - The Minister of Health may determine the development of activities
under the competence of the National Sanitary Surveillance Agency,
in specific cases that may jeopardize the health of the population.
Paragraph
7 - The deed mentioned in the previous paragraph must be published
in the Official Journal of the Union." (Re-edition).
"Article
9 - ...............................................................
Only
Paragraph - The Agency shall also count on an Advisory Council,
that shall include, at least, representatives of the Union, of the
States, of the Federal District, of the Municipalities, of producers,
of traders, of the scientific community and of users, as provided
for in regulation." (Re-edition).
"Article
15 - It is due to the Collegiate Board of Directors:
-
to
establish the strategic guidelines of the Agency;
-
to
propose to the Minister of Health governmental policies and
guidelines meant to allow the Agency to fulfil its goals;
-
to
enact norms on matters within the sphere of competence of the
Agency;
-
to
enforce and ensure enforcement of norms pertaining to sanitary
surveillance;
-
to
prepare and issue periodical reports on its activities;
-
to
judge, at appeal level, upon decisions taken by the Agency,
as per request by the parties concerned;
-
to
refer the accounting statements of the Agency to the relevant
bodies.
Paragraph
1 - The Board of Directors shall convene with the presence of at
least three directors, amongst them the Chairperson or his or her
lawful deputy, and shall decide by simple majority of votes.
Paragraph
2 - Deeds of the Agency shall be susceptible of appeal to the Collegiate
Board of Directors, with suspending effect, as last administrative
level." (Re-edition)
"Article
16 - It is due to the Chairperson:
-
to
represent the Agency in and out of court;
-
to
chair the meetings of the Collegiate Board of Directors;
-
to
decide on urgent issues, ad referendum of the Collegiate
Board of Directors;
-
to
decide in cases of tie in the deliberations of the Collegiate
Board of Directors;
-
to
appoint and dismiss civil servants, filling effective commissioned
grades and functions, and to exercise the disciplinary power,
as provided for in the legislation in force;
-
to
refer to the Advisory Council the periodical reports prepared
by the Collegiate Board of Directors;
-
to
sign contracts and agreements and to determine expenditure.
-
to
elaborate, approve and promulgate the internal regulations,
define the field of action of the organizational units and the
executive structure of the Agency;
-
to
perform the operational management of the Agency." (Re-edition)
"Article
19 - The Agency's management shall be governed by a management contract,
negotiated between its Chairperson and the Minister of Health, the
Ministers of Finance and of Planning, Budget and Management having
been previously heard, within one hundred and twenty days after
the appointment of the agency's Chairperson.
................................................................................................"
(Re-edition)
"Article
22 - ............................................................................
................................................................................................
X
- amounts obtained through investments in the financial market of
revenues provided for in numerals I through IV and VI through IX
of this Article.
................................................................................................"
(Re-edition)
"Article
23 - ............................................................................
.................................................................................................
Paragraph
6 - Laboratories created or controlled by the Public Power, producing
medicines and inputs subject to Law No. 6.360, of September 23,
1976, in the interest of Public Health, are exempt from payment
of the Sanitary Surveillance Inspection Fee.
Paragraph
7 - Renewals of registrations, authorizations and certificates are
subject to the periodical schedule and to the amounts stipulated
for the initial deeds, as provided for in Annex II.
Paragraph
8 - The provisions of the previous Article apply to the contents
of Paragraphs 1 through 8 of Article 12 and to the Only Paragraph
of Article 50 of Law No. 6.360, of 1976, of Paragraph 2 of Article
3 of Decree-Law No. 986, of October 21, 1969 and of Paragraph 3
of Article 41 of this Law." (Re-edition).
"Article
30 - The moment the National Sanitary Surveillance Agency is created,
with the publication of its internal regulation by the Collegiate
Board of Directors, the Autonomous Agency shall be automatically
vested in the exercise of its functions, and the Secretariat for
Sanitary Surveillance shall become extinct". (Re-edition).
"Article
41 - ..........................................................................
Paragraph
1 - The Agency may grant operation authorization to companies and
registration to products applicable solely to producing factories
and to merchandise geared to external markets, provided that they
do not bring about risks for public health.
Paragraph
2 - The regulation referred to in the Caput of this Article
includes within its coverage the exemption of registration.
Paragraph
3 - Companies subject to Decree-Law No. 986, of 1969, must also
comply with Article 2 of Law No.6.360, of 1976, in what regards
the authorization for operation by the Ministry of Health and the
licensing by the sanitary bodies of the Units of the Federation
where they are located". (Re-edition).
Article
2 - Law No. 9.782 shall henceforth be in force added of the following
articles:
"Article
41-A - The registration of medicines with exclusively generic names
shall have priority over that of the others, as provided for in
a deed by the Collegiate Board of Directors of the National Sanitary
Surveillance Agency". (Re-edition).
"Article
41-B - When the marketing of products subject to sanitary surveillance
that are unfit for use is verified, the company responsible for
them must issue advertisement containing a warning to the population,
within the period of time and under the conditions indicated by
the sanitary authority, and the company shall have to pay a fee
corresponding to the examination and to the previous agreement on
the informative contents by the National Sanitary Surveillance Agency".
(Re-edition).
Article
3 - The National Institute for Quality Control in Health shall be
technically subordinated to the National Sanitary Surveillance Agency,
and administratively subordinated to the Oswaldo Cruz Foundation.
Only
Paragraph - Appointments for commissioned grades and nominations
for bonus-earning functions of the National Institute for Quality
Control in Health shall be under the competence of the Minister
of Health, as per nomination by the Chairperson of the National
Sanitary Surveillance Agency, the President of Oswaldo Cruz Foundation
having been heard.
Article
4 - Food imported in its original packing shall have as its dates
of expiry, for the purposes of regularizing its registration situation
vis-à-vis of the National Sanitary Surveillance Agency, March
1st, 2000.
Article
5 - Effective civil servants from the staff of the Ministry of Health
who were in office on December 31, 1998, at the Secretariat for
Sanitary Surveillance and in the Airport, Port and Border Stations
are hereby redistributed to the National Sanitary Surveillance Agency.
Paragraph
1 - The civil servants from the National Health Foundation, redistributed
according to the provisions in the Caput, shall be included
in the same grade plan as the civil servants redistributed from
the Ministry of Health.
Paragraph
2 - In the event that the result of the inclusion mentioned in the
previous paragraph generates amounts inferior to those previously
received, the difference shall be paid as a nominally identified
advantage, the same percentages of general revision or anticipation
of salary readjustment being applicable.
Article
6 - Annex I, regarding the Demonstrative Chart of Commissioned Functions
of Sanitary Surveillance of the National Sanitary Surveillance Agency,
and Annex II to Law 9.782, of 1999, shall respectively be henceforth
in force in the form of the Annexes I and II to this Provisional
Remedy.
Article
7 - Articles 2 and 3 of Law 9.294, of July 15th, 1996, shall be
henceforth in force with the following language:
"Article
2 - ............................................................................
..............................................................................................
Paragraph
2 - The use of products referred to in the Caput is for interdicted
in aircraft and collective transport vehicles." (Re-edition)
Article
3 - ..............................................................................
...............................................................................................
Paragraph
2 - Advertisement shall contain, in the media, and according to
its characteristics, a warning, where possible oral and written,
on the ill-effects of tobacco, alcoholic beverages, medicines, therapies
and agricultural defensives, according to phrases established by
the Ministry of Health, to be used sequentially, in simultaneous
or rotational form". (Re-edition).
...............................................................................................
Paragraph
6 - The National Sanitary Surveillance Agency, in order to prevent
the circulation of false advertising of products and services subject
to its control, may demand prior presentation of copies of the advertisements
referring to these products and services, in compliance with regulation
approved by its Collegiate Board of Directors" (Re-edition)
Article
8 - Articles 3 and 57 of Law No. 6.360, of September 23, 1976, altered
by article 1 of Law No. 9.787 of February 10, 1999, shall henceforth
be in force with the following language:
"Article
3 - ............................................................................
..............................................................................................
XX
- Similar Medicine - that which contains the same active principle(s),
presents the same concentration, pharmaceutical form, means of administration,
dosage and therapeutic indication, and which is equivalent to the
reference medicine registered at the federal agency in charge of
sanitary surveillance, being allowed to differ only in characteristics
related to size and form of the product, expiry date, packaging,
labeling, excipients and vehicles, always being identified by its
trade mark;
...............................................................................................
Only
Paragraph - In the case of imported generic medicines, whose bio-equivalence
tests have been carried out outside the Country, the comparative
dissolution tests between the test-medicine, the international reference
medicine used in the bio-equivalence study and the national reference
medicine must be presented" (Re-edition)
"Article
57 - ...........................................................................
Only
Paragraph - In addition to the trademark, medicines must display,
in the pieces referred to in the Caput of this Article, in
the packaginging and in the advertising material, the Brazilian
Common Denomination or, when appropriate, the International Nonproprietary
Name, in lettering and characters in a size never under half that
of the lettering and characters of the trademark." (Re-edition)
Article
9 - The Caput of Article 2 of Law No. 9.787, of February
10, 1999, shall henceforth be in force with the following language:
"Article
2 - The federal agency responsible for sanitary surveillance shall
regulate, within one hundred and eighty days, counting as from February
11, 1999". (Re-edition).
Article
10 - Provisions of Article 15 of Law No. 5.991, of December 17,
1973, apply to medicine distributing companies.
Article
11 - Deeds performed based upon Provisional Remedy 2.039-19, of
July 28, 2000 are hereby validated.
Article
12 - This Provisional Remedy enters into force on the date of its
publication.
Article
13 - Article 4 of Decree-Law No. 986, of October 21, 1969, Article
82 of Law No. 6.360, of September 23, 1976, Article 3 of Law No.
9.005, of March 16, 1995, the Only Paragraph of Article 5, numerals
XI, XII and XIII of Article 7, Articles 32 and 39 and their paragraphs,
of Law No. 9.782, of January 26, 1999 are hereby revoked.
Brasilia,
August 25th, 2000; 179th of the Independence and 112th of the Republic.
FERNANDO HENRIQUE CARDOSO
José Serra
Martus Tavares
ANNEX I
DEMONSTRATIVE CHART OF COMMISSIONED FUNCTIONS OF
SANITARY SURVEILLANCE AT THE NATIONAL SANITARY SURVEILLANCE AGENCY
|
CODE/FCVS
|
NUMBER
|
AMOUNT
|
|
FCVS/V
|
42
|
1,170.00
|
|
FCVS/IV
|
58
|
855.00
|
|
FCVS/III
|
47
|
664.00
|
|
FCVS/II
|
58
|
585.00
|
|
FCVS/I
|
69
|
518.00
|
|
TOTAL
|
274
|
199,610.00
|
ANNEX II
SANITARY SURVEILLANCE INSPECTION FEE
|
Item
|
Generating
Facts
|
Amounts
in R$
|
Period
of Time for Renewal
|
|
1.
|
Authorization
for operation of companies, per establishment or manufacturing
unit, for each type of activity
|
|
|
|
1.1.
|
On
the medicine manufacturing sector
|
20,000
|
annual
|
|
1.2.
|
On
equipment and related matters
|
-
|
|
|
1.2.1.
|
Equipment
(nuclear medicine, computerized tomography, magnetic resonance
and cineangiocoronarygraphy)
|
10,000
|
annual
|
|
1.2.2.
|
Other
equipment, instruments and sets for diagnoses
|
5,000
|
annual
|
|
1.3.
|
Distributors
of medicines
|
15,000
|
annual
|
|
1.4.
|
Drugstores,
pharmacies and the retail trade of medical and hospital material
|
5,000
|
annual
|
|
1.5.
|
On
the food and beverages industry
|
6,000
|
annual
|
|
1.6.
|
On
the cosmetic industry
|
6,000
|
annual
|
|
1.7.
|
On
the sanitizing products industry
|
6,000
|
annual
|
|
1.8.
|
Others
|
6,000
|
annual
|
|
2.
|
Change
to the addition to the authorization (type of activity, registry
data, business merger or incorporation)
|
4,000
|
indeterminate
|
|
3.
|
Replacement
of legal representative, technical representative or cancellation
of authorization
|
exempt
|
|
|
4.
|
Certificate
of good practices in terms of manufacturing and control for
each establishment or manufacturing unit, type of activity
and line of production/marketing
|
-
|
|
|
4.1.
|
In
the country and in MERCOSUR
|
|
|
|
4.1.1.
|
Medicines
|
15,000
|
annual
|
|
4.1.2.
|
Related
matters
|
-
|
annual
|
|
4.1.2.1.
-
|
Equipment
(nuclear medicine, computerized tomography, magnetic resonance
and cineangiocoronarygraphy)
|
10,000
|
annual
|
|
4.1.2.2.
|
Other
equipment, instruments and sets for diagnoses
|
5,000
|
annual
|
|
4.1.3.
|
Food
and beverages
|
3,000
|
annual
|
|
4.1.4.
|
Cosmetics
|
3,000
|
annual
|
|
4.1.5.
|
Sanitizing
products
|
3,000
|
annual
|
|
4.2.
|
Other
countries
|
37,000
|
annual
|
|
5.
|
Registration
or Registration Renewal for Products or Group of Products
|
-
|
|
|
5.1.
|
Cosmetics
|
2,500
|
five
years
|
|
5.2.1.
|
Sanitizing
products - Category 1
|
3,000
|
five
years
|
|
5.2.2.
|
Sanitizing
products - Category 2
|
3,000
|
five
years
|
|
5.3.
|
Related
products
|
-
|
|
|
5.3.1.
|
Equipment
(nuclear medicine, computerized tomography, magnetic resonance
and cineangiocoronarygraphy)
|
20,000
|
five
years
|
|
5.3.2.
|
Other
equipment (instruments and sets for diagnosis)
|
8,000
|
five
years
|
|
5.4.
|
Medicines
|
-
|
|
|
5.4.1
|
New
|
80,000
|
five
years
|
|
5.4.2.
|
Similar
|
21,000
|
five
years
|
|
5.4.3.
|
Generic
|
6,000
|
five
years
|
|
5.6.
|
Tobacco
and similar products
|
100,000
|
annual
|
|
6.
|
Addition
or change in registration
|
-
|
|
|
6.1.
|
Presentation
|
1,800
|
indeterminate
|
|
6.2.
|
Concentration
and pharmaceutical formula
|
1,800
|
indeterminate
|
|
6.3.
|
Text
of description, form for use and labeling
|
1,800
|
indeterminate
|
|
6.4.
|
Period
of time of validity or cancellation
|
exempt
|
indeterminate
|
|
6.5.
|
Any
other
|
1,800
|
indeterminate
|
|
7.
|
Exemption
of registration
|
1,800
|
indeterminate
|
|
8.
|
Certificate,
attestation, toxicological classification, extension of use,
quota for marketing, per company, of controlled product, other
declaratory deeds
|
1,800
|
indeterminate
|
|
9.
|
Reopening
of cases and second copy of documents
|
1,800
|
indeterminate
|
|
10.
|
Agreement
in the advertising notification of products for maximum use
during six months, in cases of notification to the population
|
8,800
|
indeterminate
|
|
11.
|
Agreement
in cases of clinical research
|
10,000
|
indeterminate
|
|
12.
|
Agreement
for tax exemption and in cases of import or export of products
subject to sanitary surveillance
|
exempt
|
|
|
13.
|
Agreement
in cases of import and export for the purpose of marketing
a product subject to sanitary surveillance
|
100
|
indeterminate
|
|
14.
|
Collection
and transportation of samples for control analysis of imported
products
|
-
|
|
| |
-
within a municipality
|
150
|
indeterminate
|
| |
-
another municipality of the same state
|
300
|
indeterminate
|
| |
-
another state
|
600
|
indeterminate
|
|
15.
|
Inspection
for checking compliance with sanitary requirements
|
Exempt
|
|
|
16.
|
Activities
of sanitary control of ports, airports and borders
|
-
|
|
|
16.1.
|
Issuance
of certificates of rat and mice elimination and exemption
of same for boats
|
1,000
|
indeterminate
|
|
16.2.
|
Issuance
of manifest of disembarking passengers and crew members of
crafts, aircraft and land vehicles of international transit
|
500
|
indeterminate
|
|
16..3.
|
Issuance
of certificate of free practice
|
600
|
indeterminate
|
|
16.4.
|
Issuance
of manifest for transportation of corpse in crafts, aircraft
and land vehicles in inter-state and international transit
|
Exempt
|
|
1. Amounts in the Chart shall be reduced by:
- 15% in cases of companies with an annual turnover of less than
R$ 50.000.000,00 (fifty million reais);
- 30%, in cases of average companies with a turnover above R$
6.000.000,00 (six million reais);
- 60%, in cases of medium companies with a turnover of R$ 6.000.000,00
(six million reais) or less
- 90%, in case of small companies;
e) 95%, in cases of micro-companies, except for
items 1.3 and 1.4, the amounts for which, in cases of micro-companies,
are reduced by 90%.
2. Beverages and food shall be registered in cases
within the competence of the Ministry of Health.
3. For small and micro-companies, the fee for the
concession of Certificates of Good Practice of Manufacture and Control,
item 4, shall be collected for each establishment or manufacturing
unit.
4. Until December 31st, 1999, micro-companies shall
be exempt form the fee for the concession of Certificates of Good
Practice of Manufacture and Control, Registration or Renewal of
Registration of Products or Group of Products, items 4 and 5. The
exemption may be extended to December 31st, 2000, as per decision
by the Collegiate Board of Directors of ANVISA.
5. The fee for Registration or Registration Renewal
for medicines or group of physiotherapy medicines and homeopathic
medicines, Large Volume Parenteral Solution and Small Volume Parenteral
Solution shall be that of item 5.4.3, Generics.
6. For the purposes of Registration or Registration
Renewal, medicines shall be deemed new if they contain new molecules
and if they are covered by patents.
7. The amounts of the Chart for Registration Renewal
of Products or Groups of Products shall be reduced by 10% at each
renewal, up to the total limit of 50%.
8. The fitting of companies in the sizes provided
for in letters "b" through "d" of item 1 shall
be done starting from what is established by Laws 9.317, of December
5th, 1996 and 9.531, of December 10th, 1997.
9. The Collegiate Board of Directors of ANVISA
shall fit the provisions of items 16.1, 16.2 and 16.3 and their
discounts to the size of crafts, as per number of passengers, weight
of cargoes or as per a mixed criterion.
10. In cases of exports, the collection of fees
pertaining to generating facts listed in items 8 and 13 is exempted.
11. Special Authorizations for Operation for marketing
controlled medicines shall have 50% discounts on the value of item
1.4, with further cumulative application of the reduction dealt
with in note 1.
12. In cases where two or more authorizations for
financing are necessary for the same company as per establishment
or for authorizations for operation where only part of the activities
are regulated by ANVISA, as listed in item 1 and its sub-items,
discounts shall be granted, as provided for in a deed by the Agency's
Collegiate Board of Directors.
13. According to provisions by the Collegiate Board of Directors
of ANVISA, the addition or change of registration pertaining to
the text of medicine description, form for use and labelling, listed
in item 6.3, are exempt from the collection of the relevant fees
in cases of changes of telephone number, CGC/CNPJ or other legal
information.
14. The reduction amounts provided for in this Table are not applicable
to companies located in other countries, which are provided for
in sub-item 4.2.
|
|